- Dell Taking Further Steps To Cut Staff and Costs
- Marvel Posts Marvel-ous Profits, Sees Modest 2009
- Consumer Bankruptcies Soar in October
- Why the US Market Rallied Even Before Vote Was Over
- Fiscal Boost Needed to Lift Economy: Fed's Fisher
- World Closely Watching US Election
- GE Open to Using Bailout Money For Lending Arm
- Factory Orders Drop More than Expected
- Global Stocks Stage Rally As US Votes for President
- Oil: Fourth Biggest One-Day Gain Ever
- Investor Fear Dropping
- Election Day Long Lines Are For—Starbucks!
- Stop Trading!: Election Day Trading
- Intrade Political Futures: Will this election make the Senate Filibuster Proof?
- Big Pharma "Healthier" For Obama With Campaign Money
- Iron Man Drives Marvel's 40 Percent Earnings Growth
- More From McCain Headquarters: Will Palin Speak? (Yes)
- Accidental Dividends?
- D.R. Horton expects $800M-$900M loss in 4Q
- Boeing says 787 test flight delayed due to strike
- Unit Corp. shares rise on 3Q profit report
- PetroQuest 3rd-quarter profit more than doubles
- Columbia Sportswear cutting 75 jobs as orders slip
- Bomb explodes at Swedish hotel, 1 injured
- This year's Antarctic zone hole is 5th biggest
- Report: Drilling on federal lands could be faster
- Pinnacle West Capital profit falls 27 pct in 3Q
- Myriad Genetics hits high after solid 3Q results
NEW YORK - Shareholders of specialty chemicals maker Rohm & Haas Co. approved a $15.3 billion buyout by Dow Chemical Co. on Wednesday.
Shareholders, who voted on the deal in Philadelphia where Rohm & Haas is based, will get$78 in cash for each share they own.
Including debt, the final price tag for the specialty chemicals maker is expected to be about $18.8 billion.
The deal is expected to close early in 2009, pending regulatory approval.
Dow is keeping the Rohm & Haas name, and will use existing facilities to form an advanced materials company with annual sales of about $13 billion. Two Rohm & Haas directors will join Dow's board, bringing its total size to 14 members.
Rohm & Haas will become a subsidiary of Dow, and its shares will not be traded separately.
The acquisition marks a further move by Dow into the higher-margin specialty chemicals market, which would provide a buffer against ups and downs in basic chemical sales. Specialty chemicals have more specific uses compared with those produced as high-volume commodities for manufacturing.
The Haas family, descendants of one of the company's founders, holds about 65 million shares, a 33 percent stake worth nearly $5.1 billion based on the purchase price.
Shares of Rohm & Haas fell 57 cents to end at $68.37 and shares of Dow Chemical rose 9 cents to $25.08.



